Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Decreased by McBroom & Associates LLC

McBroom & Associates LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 18,505 shares of the medical equipment provider’s stock after selling 35 shares during the quarter. Intuitive Surgical makes up about 5.5% of McBroom & Associates LLC’s holdings, making the stock its 4th biggest holding. McBroom & Associates LLC’s holdings in Intuitive Surgical were worth $9,659,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the 4th quarter worth about $82,517,000. Exome Asset Management LLC boosted its position in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. Sycomore Asset Management grew its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 5,940 shares of company stock valued at $3,346,964. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Up 2.2 %

Shares of NASDAQ:ISRG opened at $595.70 on Tuesday. The business has a 50 day moving average price of $554.85 and a 200 day moving average price of $514.80. The company has a market cap of $212.18 billion, a price-to-earnings ratio of 92.93, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research reports. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.